Kunitoshi Kamijima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Burden in caregivers of patients with schizophrenia, depression, dementia, and stroke in Japan: comparative analysis of quality of life, work productivity, and qualitative caregiving burden.
Journal: BMC psychiatry
Published: April 02, 2024
Expression of dihomo-γ-linolenic acid and FADS1/2 and ELOVL2/5 in term rabbit placentas.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: March 07, 2024
Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder.
Journal: Current medical research and opinion
Published: September 04, 2018
Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder.
Journal: Psychiatry and clinical neurosciences
Published: February 08, 2018
Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care.
Journal: General hospital psychiatry
Published: December 19, 2017
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.
Journal: International clinical psychopharmacology
Published: October 30, 2015
Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
Journal: Psychiatry and clinical neurosciences
Published: May 15, 2014
Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: a randomized, double-blind, placebo-controlled study (ADMIRE study).
Journal: Journal of affective disorders
Published: July 03, 2013
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression.
Journal: Neuropsychiatric disease and treatment
Published: May 08, 2013
Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
Journal: The pharmacogenomics journal
Published: February 16, 2012
Analysis of depression in asthmatic patients using the Japanese version of Patient Health Questionnaire-9.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: December 14, 2011
Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Journal: Expert review of neurotherapeutics
Published: July 13, 2006
Showing 1-12 of 12
Last Updated: 09/26/2026